203 results
Page 3 of 11
6-K
EX-99.1
1rlpt6oyy2ijufjpx 8l
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
5pyq vxc0g
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
EX-99.2
yb0d9i9eqs5tt qtndq7
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
zqd10wwpc4rcavlql ow
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.2
57sn59qr3068
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.1
wwho0drsqjf9mht
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.1
p4qjdac78bpg
21 Oct 21
Current report (foreign)
3:49pm
6-K
EX-99.1
k9d0y1tbg
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.7
prkaz gnw4
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.1
mv005m34
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.5
pjovwxe4
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.2
wnvci0l90vp2k
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
hjmj8hnu
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
1s0qk
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
heiqf1
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
sr0wxf qku
13 Aug 21
51-102F3 Material Change Report
12:00am
6-K
EX-99.3
kyegxu
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
swxna6n0r9xsu5pky3
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am